Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
NCT03377725
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No patient was involved.
Conditions
Myelodysplastic Syndromes
P53 Mutation
Interventions
DRUG:
Decitabine
DRUG:
Arsenic Trioxide
Sponsor
Li Junmin